PROlonGed ExpoSure Sertraline

PHASE4CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2016

Study Completion Date

May 31, 2017

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Sertraline

Initial baseline dose of 25 mg/day. Clinician will attempt to titrate patients to at least 100 mg/day and up to 200 mg/day if tolerated by week 8.

BEHAVIORAL

Prolonged Exposure Therapy

up to 13 sessions of prolonged exposure

Trial Locations (4)

31406

Ralph H. Johnson VA Medical Center/Savannah Primary Care Clinic, Savannah

48105

Veterans Affairs Ann Arbor Healthcare System, Ann Arbor

92161

VA San Diego Healthcare System, San Diego

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

U.S. Army Medical Research and Development Command

FED

lead

VA Ann Arbor Healthcare System

FED

NCT01524133 - PROlonGed ExpoSure Sertraline | Biotech Hunter | Biotech Hunter